Rodriguez started taking semaglutide as a weekly injection in September 2022
Additionally, the medication is accessible for those needing oral semaglutide for weight loss in non-diabetics, ensuring a broader patient range, irrespective of diabetes diagnoses
[1] The FDA label for tirzepatide includes warnings about acute gallbladder disease, as GLP-1 receptor agonists have been associated with an increased risk of cholelithiasis or cholecystitis
There is still no fundamental treatment strategy that prevents seizures themselves
From consultation to treatment, our team works together to deliver expert support across medical weight loss, hormone therapy, and aesthetic services
Subjective markers Rate these on a 1 to 10 scale weekly: appetite level (how hungry you feel on average), food noise (how often you think about food), energy level, sleep quality, and mood